Session information

Symposium

[SY20] Symposium 20　Development of treatment for patients with non-small cell lung cancer harboring rare driver mutations
【E】

Fri. Feb 18, 2022 8:20 AM - 9:50 AM Room 11 and 12 (Prince Hall 1 and 2, B2F, The Prince Kyoto Takaragaike)

Chair：Hye Ryun Kim（Yonsei Cancer Center），Takehito Shukuya（Respiratory Medicine, Juntendo University）

+Add all to schedule

[SY20-1] Novel Agents for KRAS mutant NSCLC

^○Pasi A. Janne (Dana Farber Cancer Institute)

[SY20-2] New treatment options for RET fusion positive NSCLC

^○Benjamin J. Solomon (Department of Medical Oncology, Peter MacCallum Cancer Centre)

[SY20-3] Development of treatment for HER2 or EGFR Exon 20 insertion mutation-driven NSCLC

^○Kiichiro Ninomiya (Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences)

[SY20-4] Treatment strategy of lung cancer with MET, NTRK and BRAF gene aberrations: Insights from in vitro and clinical data

^○Toshio Fujino, Tetsuya Mitsudomi (Department of Surgery, Division of Thoracic Surgery, Kindai University Faculty of Medicine)

▲